Lakewood-Amedex Biotherapeutics, Inc.
LABT
$2.18
-$0.14-6.03%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 261.43% | -97.55% | -65.29% | -- | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 386.69% | -47.43% | -25.73% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 266.76% | -90.82% | -60.54% | -- | -- |
|
|
|||||
| Total Current Assets | 266.76% | -90.82% | -60.54% | -- | -- |
| Net Property, Plant & Equipment | -53.22% | -46.75% | -41.65% | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -8.24% | -4.71% | -4.71% | -- | -- |
| Total Assets | 218.34% | -76.00% | -55.02% | -- | -- |
|
|
|||||
| Total Accounts Payable | 108.68% | 160.49% | 128.83% | -- | -- |
| Total Accrued Expenses | -18.66% | 207.93% | 82.67% | -- | -- |
| Short-term Debt | -- | 712.50% | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -12.34% | 5.95% | 6.04% | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -70.61% | 296.92% | 380.44% | -- | -- |
|
|
|||||
| Total Current Liabilities | -70.61% | 296.92% | 380.44% | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 712.50% | -- | -- | -- |
| Capital Leases | -- | -92.16% | -74.42% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -71.94% | 239.78% | 270.06% | -- | -- |
|
|
|||||
| Common Stock & APIC | 45.77% | 2.93% | 2.94% | -- | -- |
| Retained Earnings | -35.39% | -8.46% | -7.77% | -- | -- |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | -- | -- |
| Total Common Equity | 731.07% | -3,487.26% | -583.92% | -- | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -96.67% | 0.00% | 0.00% | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -96.67% | 0.00% | 0.00% | -- | -- |
|
|
|||||
| Total Common Equity | 731.07% | -3,487.26% | -583.92% | -- | -- |
| Total Preferred Equity | -96.67% | 0.00% | 0.00% | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 733.85% | -3,629.13% | -579.61% | -- | -- |
|
|
|||||